- Abstract:
-
The effect of intensive glucose control on major kidney outcomes in type 2 diabetes remains unclear. To study this, the ADVANCE trial randomly assigned 11,140 participants to an intensive glucose-lowering strategy (hemoglobin A1c target 6.5% or less) or standard glucose control. Treatment effects on end-stage renal disease ((ESRD), requirement for dialysis or renal transplantation), total kidney events, renal death, doubling of creatinine to above 200 μmol/l, new-onset macroalbuminuria or mic...
Expand abstract - Publication status:
- Published
- Journal:
- Kidney international
- Volume:
- 83
- Issue:
- 3
- Pages:
- 517-523
- Publication date:
- 2013-03-05
- DOI:
- EISSN:
-
1523-1755
- ISSN:
-
0085-2538
- URN:
-
uuid:2d8c0b58-c8b4-4925-9efb-5baa6a875765
- Source identifiers:
-
377617
- Local pid:
- pubs:377617
- Copyright date:
- 2013
Journal article
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record